Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

SSE reaches final investment decision on Platin power station

(Sharecast News) - Multinational energy company SSE said on Thursday that a final investment decision has been taken to build its Platin power station in County Meath. SSE said the €300.0m, 170MW plant was designed to run on hydrotreated vegetable oil, with the potential to convert to hydrogen. Completion was expected to take place in 2028.

The FTSE 100-listed firm also said consent was being sought to run the station on natural gas to fully utilise the plant's capability to meet Ireland's energy needs.

Elsewhere, SSE said its networks' operational performance remained strong throughout Q1, as its transmission and distribution businesses continued to progress their capex programmes, increasing adjusted investment nearly 70% to around £500.0m.

On the other hand, strong renewables operational availability was offset by unfavourable weather conditions across April and May, resulting in a 4% decrease in output when compared to the same period a year earlier.

Finally, SSE stated that financial expectations set out in May remain unchanged and continue to be subject to weather, market conditions and plant availability, with the key winter months still to come.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.